Debut Plus

₹7.8

▼ -0.05 -0.64%

26 Oct 2026

BSE Listed

GSM · GSM 0
What does GSM · GSM 0 mean?
BSE · Graded Surveillance Measure (GSM 0)GSM targets fundamentally weak companies whose price doesn't square with their financials (tiny net worth or negative/extreme P/E). Practical meaning: the exchange doubts the price is backed by the business. Stage 0 is a watchlist; each higher stage makes the stock progressively harder to trade — tighter bands, full upfront margin, weekly-only trading, and at Stage IV no upward price movement at all. Exiting requires a quarterly review finding the criteria no longer met.Criteria: Shortlisted on objective financial parameters — net worth, net fixed assets, price-to-earnings multiple and market capitalisation. Stage 0 = base surveillance watchlist (identified under GSM, no graded price restriction yet); Stages I–VI add escalating curbs (price band, 100% margin, periodic call auction, settlement on a gross/trade-for-trade basis, no upward price movement).Exchange notice · 2026-03-13

Looks Health Services Limited (534422)

Volume: 700Avg Vol 1W: 2,472Avg Vol 1M: 5,61352W Range:₹3.57₹11.01
Key Ratios
Checked 1h ago
Market Cap₹8 Cr
Current Price₹7.8
Previous Close₹7.85
High / Low (52w)₹11.01 / ₹3.57
Volume700
Avg Vol (1W)2,472
Avg Vol (1M)5,613
Stock P/E390
Book Value₹14.14
Dividend Yield0%
ROE15.76%
ROA18.62%
Revenue (TTM)—
Revenue Growth—
Profit Margin6.98%
Total Debt—
Shares Outstanding1 Cr
Face Value—
EPS (TTM)₹0.02
P/B0.55
Debt / Equity0
50 DMA₹9.13
200 DMA₹8
Day change-0.64%
SurveillanceGSM · GSM 0
Price Chart
₹7.8▲ 52.34% · 1Y
₹11₹43.4L
2025-10-27
2026-10-26

20-day avg volume: 6K shares

Pros
  • Healthy return on equity of 15.8%.
  • Company is almost debt-free.
  • Stock trades below its book value.
Cons
  • Stock trades at a high P/E of 390.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2012
Revenue₹0 Cr
EBITDA₹0 Cr
Net Profit₹0 Cr
EPS-4.97
Balance Sheet
MetricMar 2012
Total Assets₹4 Cr
Total Liabilities₹1 Cr
Equity₹3 Cr
Total Debt—
Cash Flow
MetricMar 2012
Operating₹-1 Cr
Investing₹-2 Cr
Financing₹4 Cr
Free Cash Flow₹-1 Cr
Shareholding
Promoter 0% Institutions 16.99% Public 83.01%
Efficiency & Working Capital
ROCE0.2%
Interest Coverage0
Dividend Payout—
Debtor Days0 d
Inventory Days276 d
Payable Days44 d
Cash Conversion Cycle233 d
Working Capital Days276 d
Shareholding Details

As of 2026-09-30

Promoter0%
FII17%
DII0%
Institutions17%
Public83%
Promoter Pledge—
No. of Shareholders10,805
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters20.2%20.2%20.2%20.2%20.2%20.2%13.3%10.4%0%0%0%0%
FIIs0%0%0%0%0%0%6.9%9.3%17%17%17%17%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public79.8%79.8%79.8%79.8%79.8%79.8%79.8%80.3%83%83%83%83%
Promoter Pledge0%0%0%0%0%0%0%0%————
No. of Shareholders12,37612,11811,67611,48511,54611,65011,55211,42011,26411,62911,23510,805
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Wave Capital LtdPublic Shareholding10%10,47,675
Aio Growth Capital Fund SpcPublic Shareholding7%7,36,255
Pl.m.palaniappan .Public Shareholding4.5%4,69,353
P.ram Meyyappan .Public Shareholding4.3%4,49,729
M C G Investments Private LimitedPublic Shareholding3.6%3,79,067
Ramesh Krishna KulayePublic Shareholding2.4%2,49,200
Jaswant Kantilal ParmarPublic Shareholding2.2%2,32,400
Jayalakshmi Pl .Public Shareholding1.9%2,00,685
El Dorado Biotech Pvt. Ltd.Public Shareholding1.7%1,80,600
Mahendra Chand Singhvi .Public Shareholding1.2%1,22,619
Mittal Prafull MistryPublic Shareholding1.1%1,17,000
Madhusudan Rao PolineniPublic Shareholding1.1%1,12,599
Maruti Shankar GaudePublic Shareholding1.1%1,09,767
Board of Directors
NameDesignationYear
Monika JoshiChairman / Executive Director / WTD / MD2026
Mihir GanappaNon-Exec & Non-Independent Dir2026
Dhruv Pravinbhai RajgorIndependent Non Exe. Director2026
Bhavin Mahendrakumar HirparaIndependent Non Exe. Director2026
Vandanaben SheladiyaCompany Sec. & Compli. Officer2026
Segments — Geography
RegionRevenueShare
Within India₹1 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10121111
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-04Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000000
2026000000
2026000000
Insider / Designated-Person Trades

14 recent disclosure(s)

PRITESH DOSHIDisposal · 22,500
MAXGAINZ FINSERVE PVT LTDDisposal · 1,50,000
MAXGAINZ FINSERVE PVT LTDDisposal · 2,66,944
MAXGAINZ FINSERVE PVT LTDDisposal · 1,50,000
MAXGAINZ FINSERVE PVT LTDDisposal · 50,000
MAXGAINZ FINSERVE PVT LTDDisposal · 50,000
Substantial Acquisitions (SAST)

13 disclosure(s)

Market30/12/2025 · 22,500
Market29/12/2025 · 1,50,000
Market26/12/2025 · 2,66,944
Market24/12/2025 · 1,50,000
Market23/12/2025 · 50,000
Market22/12/2025 · 50,000
Company Information
Incorporated2011
ChairmanMonika Joshi
AuditorKPSJ & Associates LLP
Investor Email[email protected]
🌐 www.looksclinic.in ↗

📍 Shop No-210 Gala Hub Bopal, Daskroi, Ahmedabad, Gujarat, 400053

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search